InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

Bionano Genomics, Inc.

BNGO Clue Score56
United States Fiscal year ends December CIK 0001411690
$1.44 -1.71% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.44 −71.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Sep 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue9.5Operating income−23.2Net income−23.4Fiscal year 2018Revenue12.0 +26.3%Operating income−20.4Net income−18.5Fiscal year 2019Revenue10.1 −15.6%Operating income−25.9Net income−29.8Fiscal year 2020Revenue8.5 −16.1%Operating income−38.6Net income−41.1Fiscal year 2021Revenue18.0 +111.5%Operating income−77.1Net income−72.4EPS, diluted−0.26Fiscal year 2022Revenue27.8 +54.6%Operating income−131.7Net income−132.6EPS, diluted−4.58Fiscal year 2023Revenue36.1 +29.9%Operating income−215.2Net income−232.5EPS, diluted−408.60Fiscal year 2024Revenue30.8 −14.8%Operating income−104.0Net income−112.0EPS, diluted−88.13Fiscal year 2025Revenue28.5 −7.4%Operating income−33.3Net income−26.4EPS, diluted−4.85
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 9.5 12.0 10.1 8.5 18.0 27.8 36.1 30.8 28.5
Growth +26.3% −15.6% −16.1% +111.5% +54.6% +29.9% −14.8% −7.4%
Operating income −23.2 −20.4 −25.9 −38.6 −77.1 −131.7 −215.2 −104.0 −33.3
Net income −23.4 −18.5 −29.8 −41.1 −72.4 −132.6 −232.5 −112.0 −26.4
Growth
EPS, diluted n/a n/a n/a n/a −0.26 −4.58 −408.60 −88.13 −4.85

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−244.3%Net margin−245.8%Free cash flow margin−229.7%Fiscal year 2018Operating margin−170.1%Net margin−154.1%Free cash flow margin−169.0%Fiscal year 2019Operating margin−255.4%Net margin−294.3%Free cash flow margin−292.1%Fiscal year 2020Operating margin−453.4%Net margin−483.4%Free cash flow margin−450.6%Fiscal year 2021Operating margin−428.8%Net margin−402.8%Fiscal year 2022Operating margin−473.7%Net margin−476.9%Fiscal year 2023Operating margin−596.0%Net margin−643.7%Fiscal year 2024Operating margin−337.9%Net margin−364.0%Fiscal year 2025Operating margin−116.9%Net margin−92.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −244.3% −170.1% −255.4% −453.4% −428.8% −473.7% −596.0% −337.9% −116.9%
Net margin −245.8% −154.1% −294.3% −483.4% −402.8% −476.9% −643.7% −364.0% −92.6%
Free cash flow margin −229.7% −169.0% −292.1% −450.6% n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−20.8Capital expenditure−1.0Free cash flow−21.8Fiscal year 2018Operating cash flow−19.9Capital expenditure−0.3Free cash flow−20.3Fiscal year 2019Operating cash flow−29.5Capital expenditure−0.1Free cash flow−29.6Fiscal year 2020Operating cash flow−38.3Capital expenditure0.0Free cash flow−38.3Fiscal year 2021Operating cash flow−71.9Fiscal year 2022Operating cash flow−124.8Fiscal year 2023Operating cash flow−125.2Fiscal year 2024Operating cash flow−68.9Fiscal year 2025Operating cash flow−16.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −20.8 −19.9 −29.5 −38.3 −71.9 −124.8 −125.2 −68.9 −16.3
Capital expenditure −1.0 −0.3 −0.1 0.0 n/a n/a n/a n/a n/a
Free cash flow −21.8 −20.3 −29.6 −38.3 n/a n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash1.0Total debt6.7Net cash (debt)−5.7Shareholders’ equity−50.2Fiscal year 2018Cash16.5Total debt9.0Net cash (debt)7.5Shareholders’ equity10.1Debt to equity0.89Fiscal year 2019Cash17.3Total debt20.1Net cash (debt)−2.8Shareholders’ equity3.6Debt to equity5.56Fiscal year 2020Cash38.4Total debt16.3Net cash (debt)22.1Shareholders’ equity35.1Debt to equity0.47Fiscal year 2021Cash24.6Total debt0.0Net cash (debt)24.6Shareholders’ equity337.1Debt to equity0.00Fiscal year 2022Cash5.1Shareholders’ equity249.4Fiscal year 2023Cash17.9Shareholders’ equity96.2Fiscal year 2024Cash9.2Shareholders’ equity35.4Fiscal year 2025Cash3.0Shareholders’ equity44.4
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.0 16.5 17.3 38.4 24.6 5.1 17.9 9.2 3.0
Total debt 6.7 9.0 20.1 16.3 0.0 n/a n/a n/a n/a
Net cash (debt) −5.7 7.5 −2.8 22.1 24.6 n/a n/a n/a n/a
Shareholders’ equity −50.2 10.1 3.6 35.1 337.1 249.4 96.2 35.4 44.4
Debt to equity n/a 0.89 5.56 0.47 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−20.8 −19.9 −29.5 −38.3 −71.9 −124.8 −125.2 −68.9 −16.3
Growth
1.5 1.3 1.1 1.5 3.4 9.6 13.7 14.0 9.5
Investment
−1.0 −0.3 −0.1 0.0 n/a n/a n/a n/a n/a
calc −21.8 −20.3 −29.6 −38.3 n/a n/a n/a n/a n/a
Growth
−1.0 −0.3 −0.1 −2.5 −278.1 82.8 24.2 73.8 −12.7
Financing
17.6 35.8 30.4 61.9 336.1 23.0 113.8 −13.7 24.0

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.